Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/24/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Vishwanath R. Lingappa

Wrong Dr. Vishwanath R. Lingappa?
 
Background

Employment History

  • Chief Technology Officer and Co-Chief Executive Officer
    Prosetta Antiviral Inc
  • Chief Technology Officer and Co-Chief Executive Officer and Member of the Board of Directors
    Prosetta Antiviral Inc
  • Senior Scientist
    Research Institute of California Pacific Medical Center

Board Memberships and Affiliations

Education

  • MD
  • PhD
  • M.D. degree
    Cornell University Medical College
  • B.A. degree
    Swarthmore College
  • Ph.D. degree
    The Rockefeller University
26 Total References
Web References
Prof. Vishwanath R. ...
www.vipragen.com, 6 Nov 2013 [cached]
Prof. Vishwanath R. Lingappa, MD, PhD
Vishwanath R. Lingappa is currently Chief Technology Officer and Co-CEO of Prosetta Antiviral, Inc, in San Francisco. In these roles he is responsible for the advancement of Prosetta's scientific programs in both anti-viral drug development and protein bioconformatics. He received a B.A. degree from Swarthmore College in 1975, a Ph.D. degree from The Rockefeller University in 1979, and a M.D. degree from Cornell University Medical College in 1980. Dr. Lingappa completed residency training in Internal Medicine before joining the faculty in the Departments of Physiology and Medicine at the University of California, San Francisco (UCSF) in 1982, where he ran an NIH-funded basic research laboratory for over 20 years. It was during this time that the core discoveries on which Prosetta's science is based were made and refined in his laboratory.
At UCSF he was heavily involved in medical student and resident teaching and training, and was author and co-editor of highly acclaimed textbooks in physiology, pathophysiology and cell biology. He has supervised some 40 pre and post-doctoral trainees, 8 of whom received Ph.D. degrees under his guidance. He has co-authored over 90 publications. He was promoted to Professor in 1991. Dr. Lingappa also practiced internal medicine at San Francisco General Hospital for over 26 years. He maintains voluntary positions as Senior Scientist at the Research Institute of California Pacific Medical Center and Emeritus Professor of Physiology at UCSF. He is recipient of a Kaiser Award for excellence in teaching (1990) and is a Fellow of the American Association for the Advancement of Science (2004).
Vishwanath R. Lingappa, MD, ...
www.prosetta.com, 5 Feb 2014 [cached]
Vishwanath R. Lingappa, MD, PhD
Chief Technology Officer and Co-CEO and Member of the Board of Directors, Prosetta Antiviral, Inc.
Vishwanath R. Lingappa is currently Chief Technology Officer and CoCEO of Prosetta Antiviral, Inc., in San Francisco. In these roles he is responsible for the advancement of Prosetta's scientific programs in both anti-viral drug development and protein bioconformatics. He received the B.A. degree from Swarthmore College in 1975, the Ph.D. degree from The Rockefeller University in 1979, and the M.D. degree from Cornell University Medical College in 1980. Dr. Lingappa completed residency training in Internal Medicine before joining the faculty in the Departments of Physiology and Medicine at the University of California, San Francisco (UCSF) in 1982, where he ran an NIH-funded basic research laboratory for over 20 years. It was during this time that the core discoveries on which Prosetta's science is based were made and refined in his laboratory. At UCSF he was heavily involved in medical student and resident teaching and training, and was author and co-editor of highly acclaimed textbooks in physiology, pathophysiology and cell biology. He has supervised some 40 pre and post-doctoral trainees, 8 of whom received the Ph.D. degree under his guidance. He has co-authored over 90 publications. He was promoted to Professor in 1991. Dr. Lingappa also practiced internal medicine at San Francisco General Hospital for over 26 years. He maintains voluntary positions as Senior Scientist at the Research Institute of California Pacific Medical Center and Emeritus Professor of Physiology at UCSF. He is recipient of a Kaiser Award for excellence in teaching (1990) and is a Fellow of the American Association for the Advancement of Science (2004).
Business and Scientific Advisory Board | Akonni Biosystems
www.akonni.com, 9 Mar 2014 [cached]
Vishwanath R. Lingappa, M.D., Ph.D. An emeritus professor of Physiology at the University of California San Francisco, Dr. Lingappa is Chief Technology Officer and CoCEO of Prosetta Bioconformatics.
Vishwanath R. Lingappa, MD, ...
www.prosetta.com, 5 Feb 2014 [cached]
Vishwanath R. Lingappa, MD, PhD
Chief Technology Officer and Co-CEO and Member of the Board of Directors, Prosetta Antiviral, Inc.
Vishwanath R. Lingappa is currently Chief Technology Officer and CoCEO of Prosetta Antiviral, Inc, in San Francisco. In these roles he is responsible for the advancement of Prosetta's scientific programs in both anti-viral drug development and protein bioconformatics. He received the B.A. degree from Swarthmore College in 1975, the Ph.D. degree from The Rockefeller University in 1979, and the M.D. degree from Cornell University Medical College in 1980. Dr. Lingappa completed residency training in Internal Medicine before joining the faculty in the Departments of Physiology and Medicine at the University of California, San Francisco (UCSF) in 1982, where he ran an NIH-funded basic research laboratory for over 20 years. It was during this time that the core discoveries on which Prosetta's science is based were made and refined in his laboratory. At UCSF he was heavily involved in medical student and resident teaching and training, and was author and co-editor of highly acclaimed textbooks in physiology, pathophysiology and cell biology. He has supervised some 40 pre and post-doctoral trainees, 8 of whom received the Ph.D. degree under his guidance. He has co-authored over 90 publications. He was promoted to Professor in 1991. Dr. Lingappa also practiced internal medicine at San Francisco General Hospital for over 26 years. He maintains voluntary positions as Senior Scientist at the Research Institute of California Pacific Medical Center and Emeritus Professor of Physiology at UCSF. He is recipient of a Kaiser Award for excellence in teaching (1990) and is a Fellow of the American Association for the Advancement of Science (2004).
Prosetta Antiviral Inc Enters into Multi-year Collaboration with Bristol-Myers Squibb | Prosetta Antiviral, Inc
www.prosetta.com, 11 Feb 2013 [cached]
Vishwanath R. Lingappa, MD, PhD, Prosetta's Chief Technology Officer and Co-CEO, stated, "We greatly value this opportunity to collaborate with Bristol-Myers Squibb scientists in a joint program dedicated to a completely new approach to protecting human health against viral infections."
Other People with the name "Lingappa":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304